I-Ming Chen

发表

Gene expression profiling of adult acute myeloid leukemia identifies novel biologic clusters for risk classification and outcome prediction.

Erik Andries, Donna P Ankerst, Huining Kang, 2006, Blood.

Appendix : supplementary information : gene expression profiling reveals novel genes for improved risk classification and outcome prediction in pediatric acute lymphoblastic leukemia : identification, validation, and cloning of OPAL1.

Robert Veroff, Paul Helman, Edward J. Bedrick, 2004 .

Rise and fall of subclones from diagnosis to relapse in pediatric B-acute lymphoblastic leukaemia

Jing Ma, Xiaotu Ma, Jinghui Zhang, 2015, Nature Communications.

Genomic analyses identify recurrent MEF2D fusions in acute lymphoblastic leukaemia

Guido Marcucci, Marco Marra, Zhaohui Gu, 2016, Nature Communications.

Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome.

Kevin K Dobbin, Edward J Bedrick, Walker Wharton, 2010, Blood.

Aberrant STAT5 and PI3K/mTOR pathway signaling occurs in human CRLF2-rearranged B-precursor acute lymphoblastic leukemia.

Julie M Gastier-Foster, Brent L Wood, M. Loh, 2012, Blood.

Mesoporous Silica Nanoparticle-Supported Lipid Bilayers (Protocells) for Active Targeting and Delivery to Individual Leukemia Cells.

Cheryl L. Willman, C. Jeffrey Brinker, Jason L. Townson, 2016, ACS nano.

Sequential phase II Southwest Oncology Group studies (S0112 and S0301) of daunorubicin and cytarabine by continuous infusion, without and with ciclosporin, in older patients with previously untreated acute myeloid leukaemia

H. Gundacker, M. Slovak, F. Appelbaum, 2010, British journal of haematology.